TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $20,000 | -62.3% | 14,984 | 0.0% | 0.00% | -62.5% |
| Q4 2018 | $53,000 | +29.3% | 14,984 | 0.0% | 0.01% | +33.3% |
| Q3 2018 | $41,000 | -22.6% | 14,984 | 0.0% | 0.01% | -25.0% |
| Q2 2018 | $53,000 | +15.2% | 14,984 | 0.0% | 0.01% | +14.3% |
| Q1 2018 | $46,000 | -51.1% | 14,984 | 0.0% | 0.01% | -50.0% |
| Q4 2017 | $94,000 | -7.8% | 14,984 | 0.0% | 0.01% | -12.5% |
| Q3 2017 | $102,000 | -4.7% | 14,984 | 0.0% | 0.02% | -5.9% |
| Q2 2017 | $107,000 | -22.5% | 14,984 | 0.0% | 0.02% | -22.7% |
| Q1 2017 | $138,000 | +130.0% | 14,984 | 0.0% | 0.02% | +144.4% |
| Q4 2016 | $60,000 | +106.9% | 14,984 | +100.0% | 0.01% | +125.0% |
| Q3 2016 | $29,000 | -9.4% | 7,492 | 0.0% | 0.00% | -20.0% |
| Q2 2016 | $32,000 | -8.6% | 7,492 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $35,000 | -53.3% | 7,492 | 0.0% | 0.01% | -54.5% |
| Q4 2015 | $75,000 | +33.9% | 7,492 | 0.0% | 0.01% | +22.2% |
| Q3 2015 | $56,000 | -84.2% | 7,492 | 0.0% | 0.01% | -83.9% |
| Q2 2015 | $355,000 | +624.5% | 7,492 | +66.5% | 0.06% | +600.0% |
| Q1 2014 | $49,000 | – | 4,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
| Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
| DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
| Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
| A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
| FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
| Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
| Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
| Man Group plc | 737,715 | $2,634,000 | 0.01% |